| Product NDC: | 59762-0540 |
| Proprietary Name: | Glipizide |
| Non Proprietary Name: | glipizide |
| Active Ingredient(s): | 2.5 mg/1 & nbsp; glipizide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 59762-0540 |
| Labeler Name: | Greenstone LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020329 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20130529 |
| Package NDC: | 59762-0540-1 |
| Package Description: | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (59762-0540-1) |
| NDC Code | 59762-0540-1 |
| Proprietary Name | Glipizide |
| Package Description | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (59762-0540-1) |
| Product NDC | 59762-0540 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | glipizide |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20130529 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Greenstone LLC |
| Substance Name | GLIPIZIDE |
| Strength Number | 2.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient] |